Effect of donor/recipient sex on relapse among patients who underwent transplantation for CML, AML, and ALL
. | Adjusted hazard ratio* . | 95% CI . | P . |
|---|---|---|---|
| CML | |||
| Other sex combinations | 1 | NA | NA |
| Female/male | 0.68 | 0.48-0.98 | .04 |
| AML | |||
| Other sex combinations | 1 | NA | NA |
| Female/male | 0.87 | 0.65-1.15 | .33 |
| ALL | |||
| Other sex combinations | 1 | NA | NA |
| Female/male | 0.77 | 0.59-1.02 | .07 |
. | Adjusted hazard ratio* . | 95% CI . | P . |
|---|---|---|---|
| CML | |||
| Other sex combinations | 1 | NA | NA |
| Female/male | 0.68 | 0.48-0.98 | .04 |
| AML | |||
| Other sex combinations | 1 | NA | NA |
| Female/male | 0.87 | 0.65-1.15 | .33 |
| ALL | |||
| Other sex combinations | 1 | NA | NA |
| Female/male | 0.77 | 0.59-1.02 | .07 |
NA indicates not applicable.
Adjusted for patient and donor age, GVHD prophylaxis, disease status, conditioning regimen, and patient/donor CMV serostatus.